Quantifying the Burden of Rhodesiense Sleeping Sickness in Urambo District, Tanzania

Background Human African trypanosomiasis is a severely neglected vector-borne disease that is always fatal if untreated. In Tanzania it is highly focalised and of major socio-economic and public health importance in affected communities. Objectives This study aimed to estimate the public health burden of rhodesiense HAT in terms of DALYs and financial costs in a highly disease endemic area of Tanzania using hospital records. Materials and Methods Data was obtained from 143 patients admitted in 2004 for treatment for HAT at Kaliua Health Centre, Urambo District. The direct medical and other indirect costs incurred by individual patients and by the health services were calculated. DALYs were estimated using methods recommended by the Global Burden of Disease Project as well as those used in previous rhodesiense HAT estimates assuming HAT under reporting of 45%, a figure specific for Tanzania. Results The DALY estimate for HAT in Urambo District with and without age-weighting were 215.7 (95% CI: 155.3–287.5) and 281.6 (95% CI: 209.1–362.6) respectively. When 45% under-reporting was included, the results were 622.5 (95% CI: 155.3–1098.9) and 978.9 (95% CI: 201.1–1870.8) respectively. The costs of treating 143 patients in terms of admission costs, diagnosis, hospitalization and sleeping sickness drugs were estimated at US$ 15,514, of which patients themselves paid US$ 3,673 and the health services US$ 11,841. The burden in terms of indirect non-medical costs for the 143 patients was estimated at US$ 9,781. Conclusions This study shows that HAT imposes a considerable burden on affected rural communities in Tanzania and stresses the urgent need for location- and disease-specific burden estimates tailored to particular rural settings in countries like Tanzania where a considerable number of infectious diseases are prevalent and, due to their focal nature, are often concentrated in certain locations where they impose an especially high burden.

[1]  M. Eisler,et al.  Neglected and endemic zoonoses , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[2]  I. Nyamongo,et al.  The treatment pathways followed by cases of human African trypanosomiasis in western Kenya and eastern Uganda , 2009, Annals of tropical medicine and parasitology.

[3]  E. Fèvre,et al.  The Burden of Human African Trypanosomiasis , 2008, PLoS neglected tropical diseases.

[4]  C. Sindato,et al.  Challenges in the diagnosis and management of sleeping sickness in Tanzania: a case report. , 2008, Tanzania journal of health research.

[5]  Mark EJ Woolhouse,et al.  Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda , 2008, BMC public health.

[6]  P. Simarro,et al.  Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next> , 2008, PLoS medicine.

[7]  S. Cleaveland,et al.  Health-seeking behaviour of human brucellosis cases in rural Tanzania , 2007, BMC public health.

[8]  E. Fèvre,et al.  Sleeping sickness--a re-emerging disease in the Serengeti? , 2007, Travel medicine and infectious disease.

[9]  M. Boelaert,et al.  Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo , 2007, Tropical medicine & international health : TM & IH.

[10]  M. Boelaert,et al.  Human African Trypanosomiasis in a Rural Community, Democratic Republic of Congo , 2007, Emerging infectious diseases.

[11]  Asia Maccawi Ahmed,et al.  UNDP, 2006, beyond Scarcity: Power, Poverty and Global Water Circes Human Development Report , 2006 .

[12]  P. Hotez,et al.  The antipoverty vaccines. , 2006, Vaccine.

[13]  E. Fèvre,et al.  Crisis, what crisis? Control of Rhodesian sleeping sickness. , 2006, Trends in parasitology.

[14]  L. Matemba,et al.  Drug‐resistance of Trypanosoma b. rhodesiense isolates from Tanzania , 2006, Tropical medicine & international health : TM & IH.

[15]  J. Massaga,et al.  User charges in public health facilities in Tanzania: effect on revenues, quality of services and people's health-seeking behaviour for malaria illnesses in Korogwe district , 2006, Health services management research.

[16]  Jeffrey D Sachs,et al.  Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria , 2006, PLoS medicine.

[17]  Peter J Hotez,et al.  “Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the Poor , 2005, PLoS medicine.

[18]  J. McDermott,et al.  Quantifying the level of under‐detection of Trypanosoma brucei rhodesiense sleeping sickness cases , 2005, Tropical medicine & international health : TM & IH.

[19]  A. Shaw,et al.  Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda , 2004, Annals of tropical medicine and parasitology.

[20]  L. Matemba,et al.  Sleeping sickness situation in Tanzania , 2004 .

[21]  N. Crafts,et al.  Welfare Implications of Hiv/Aids , 2003, SSRN Electronic Journal.

[22]  H. Mshinda,et al.  Inequities among the very poor: health care for children in rural southern Tanzania , 2003, The Lancet.

[23]  R. Snow,et al.  Too poor to pay: charging for insecticide‐treated bednets in highland Kenya , 2002, Tropical medicine & international health : TM & IH.

[24]  M E Woolhouse,et al.  Risk factors for human disease emergence. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[25]  A. Moore,et al.  Re‐emergence of epidemic sleeping sickness in southern Sudan , 2001, Tropical medicine & international health : TM & IH.

[26]  C. M. Bilenge,et al.  Sleeping sickness resurgence in the DRC: the past decade , 2001, Tropical medicine & international health : TM & IH.

[27]  S. Kibona Rhodesiense sleeping sickness: Re-emerging as a public health problem , 2001 .

[28]  B. Pécoul,et al.  Drugs for 'neglected diseases': a bitter pill. , 2000, Tropical medicine & international health : TM & IH.

[29]  B. Pécoul,et al.  Editorial: Drugs for ‘neglected diseases’: a bitter pill , 2000, Nederlands tijdschrift voor geneeskunde.

[30]  E. Matovu,et al.  Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda. , 1999, Annals of tropical medicine and parasitology.

[31]  W. Fawzi,et al.  The double burden of HIV infection and tuberculosis in sub-Saharan Africa. , 1997, The New England journal of medicine.

[32]  J. Grant State of the World's Children 1992 , 1992 .

[33]  Carol Bellamy,et al.  'The state of the world's children'. , 1985, People Count.

[34]  C. Hatton,et al.  Reducing the Risks , 1968, Nature.

[35]  E. Ayiemba Population and Housing Census , 2012 .

[36]  L. Matemba Epidemiology of human African trypanosomiasis in western Tanzania , 2009 .

[37]  E. Fèvre,et al.  Human African trypanosomiasis: Epidemiology and control. , 2006, Advances in parasitology.

[38]  S. Welburn,et al.  Sleeping sickness: a tale of two diseases. , 2001, Trends in parasitology.

[39]  C. Murray,et al.  Global burden of disease , 1997, The Lancet.

[40]  J. Gouteux,et al.  Le coût du traitement individuel de la trypanosomiase à T. B. GAMBIENSE dans le foyer du Niari (Congo) , 1987 .

[41]  J. Gouteux,et al.  [Cost of the individual treatment of Trypanosoma brucei gambiense trypanosomiasis in a focus of infection in Niari (Congo)]. , 1987, Medecine tropicale : revue du Corps de sante colonial.